Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

Mesenchymal stem cells (MSC) are under investigation as a therapy for a variety of disorders. Although animal models show long term regenerative and immunomodulatory effects of MSC, the fate of MSC after infusion remains to be elucidated. In the present study the localization and viability of MSC wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., Hoogduijn, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458305/
https://www.ncbi.nlm.nih.gov/pubmed/23056000
http://dx.doi.org/10.3389/fimmu.2012.00297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458305/
https://www.ncbi.nlm.nih.gov/pubmed/23056000
http://dx.doi.org/10.3389/fimmu.2012.00297

Ejemplares similares